101
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Solid amorphous formulations for enhancing solubility and inhibiting Erlotinib crystallization during gastric-to-intestinal transfer

, , , &
Pages 697-707 | Received 05 Nov 2022, Accepted 02 Jul 2023, Published online: 15 Jul 2023

References

  • Baird JA, Taylor LS. 2012. Evaluation of amorphous solid dispersion properties using thermal analysis techniques. Adv Drug Deliv Rev. 64(5):396–421. doi:10.1016/j.addr.2011.07.009.
  • Beyerinck RA, Ray RJ, Dobry DE, Settell DM. 2010. Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles (United States Patent No. US7780988B2).
  • Bhattacharya S, Suryanarayanan R. 2009. Local mobility in amorphous pharmaceuticals—characterization and implications on stability. J Pharm Sci. 98(9):2935–2953. doi:10.1002/jps.21728.
  • Cabral H, Kataoka K. 2014. Progress of drug-loaded polymeric micelles into clinical studies. J Control Release. 190:465–476. doi:10.1016/j.jconrel.2014.06.042.
  • Davis MT, Potter CB, Walker GM. 2018. Downstream processing of a ternary amorphous solid dispersion: the impacts of spray drying and hot melt extrusion on powder flow, compression and dissolution. Int J Pharm. 544(1):242–253. doi:10.1016/j.ijpharm.2018.04.038.
  • Descamps M, Willart JF, Dudognon E, Caron V. 2007. Transformation of pharmaceutical compounds upon milling and comilling: the role of Tg. J Pharm Sci. 96(5):1398–1407. doi:10.1002/jps.20939.
  • Djuris J, Nikolakakis I, Ibric S, Djuric Z, Kachrimanis K. 2013. Preparation of carbamazepine–Soluplus® solid dispersions by hot-melt extrusion, and prediction of drug–polymer miscibility by thermodynamic model fitting. Eur J Pharm Biopharm. 84(1):228–237. doi:10.1016/j.ejpb.2012.12.018.
  • Ghebremeskel AN, Vemavarapu C, Lodaya M. 2007. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer–surfactant combinations using solubility parameters and testing the processability. Int J Pharm. 328(2):119–129. doi:10.1016/j.ijpharm.2006.08.010.
  • Greenhalgh DJ, Williams AC, Timmins P, York P. 1999. Solubility parameters as predictors of miscibility in solid dispersions. J Pharm Sci. 88(11):1182–1190. doi:10.1021/js9900856.
  • Guan Q, Ma Q, Zhao Y, Jiang X, Zhang H, Liu M, Wang Z, Han J. 2021. Cellulose derivatives as effective recrystallization inhibitor for ternary ritonavir solid dispersions: in vitro-in vivo evaluation. Carbohydr Polym. 273:118562. doi:10.1016/j.carbpol.2021.118562.
  • Han R, Xiong H, Ye Z, Yang Y, Huang T, Jing Q, Lu J, Pan H, Ren F, Ouyang D. 2019. Predicting physical stability of solid dispersions by machine learning techniques. J Control Release. 311–312:16–25. doi:10.1016/j.jconrel.2019.08.030.
  • Huang L, Gao S. 2009. Hydrochloride and its solid amorphous dispersion.
  • Jahangiri A, Khalilzad F, Barghi L. 2022. Dissolution improvement of binary solid dispersions of erlotinib prepared by one-step electrospray method. Biol Methods Protoc. 7(1):bpac001. doi:10.1093/biomethods/bpac001.
  • Kalepu S, Nekkanti V. 2015. Insoluble drug delivery strategies: review of recent advances and business prospects. Acta Pharm Sin B. 5(5):442–453. doi:10.1016/j.apsb.2015.07.003.
  • Mahmah O, Tabbakh R, Kelly A, Paradkar A. 2014. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine. J Pharm Pharmacol. 66(2):275–284. doi:10.1111/jphp.12099.
  • Meena K, Choudhary D. 2019. Enhancement of solubility and dissolution rate of erlotinib hydrochloride by solid dispersion technique with poloxamer 188: preparation and in-vitro evaluation.
  • Miller DA, DiNunzio JC, Yang W, McGinity JW, Williams RO. 2008. Enhanced in vivo absorption of itraconazole via stabilization of supersaturation following acidic-to-neutral pH transition. Drug Dev Ind Pharm. 34(8):890–902. doi:10.1080/03639040801929273.
  • Miller WK, Morgen MM. 2014. Solid dispersions of low-water solubility actives (World Intellectual Property Organization Patent No. WO2014126969A1). https://patents.google.com/patent/WO2014126969A1/en?oq=2014/126969.
  • Mudie DM, Buchanan S, Stewart AM, Smith A, Shepard KB, Biswas N, Marshall D, Ekdahl A, Pluntze A, Craig CD, et al. 2020. A novel architecture for achieving high drug loading in amorphous spray dried dispersion tablets. Int J Pharm X. 2:100042. doi:10.1016/j.ijpx.2020.100042.
  • Otsuka N, Ueda K, Ohyagi N, Shimizu K, Katakawa K, Kumamoto T, Higashi K, Yamamoto K, Moribe K. 2015. An insight into different stabilization mechanisms of phenytoin derivatives supersaturation by HPMC and PVP. J Pharm Sci. 104(8):2574–2582. doi:10.1002/jps.24527.
  • Palmelund H, Madsen CM, Plum J, Müllertz A, Rades T. 2016. Studying the propensity of compounds to supersaturate: a practical and broadly applicable approach. J Pharm Sci. 105(10):3021–3029. doi:10.1016/j.xphs.2016.06.016.
  • Repka MA, McGinity JW. 2000. Influence of vitamin E TPGS on the properties of hydrophilic films produced by hot-melt extrusion. Int J Pharm. 202(1–2):63–70. doi:10.1016/S0378-5173(00)00418-X.
  • Sarode AL, Sandhu H, Shah N, Malick W, Zia H. 2013. Hot melt extrusion (HME) for amorphous solid dispersions: predictive tools for processing and impact of drug–polymer interactions on supersaturation. Eur J Pharm Sci. 48(3):371–384. doi:10.1016/j.ejps.2012.12.012.
  • Sawicki E, Schellens JHM, Beijnen JH, Nuijen B. 2016. Inventory of oral anticancer agents: pharmaceutical formulation aspects with focus on the solid dispersion technique. Cancer Treat Rev. 50:247–263. doi:10.1016/j.ctrv.2016.09.012.
  • Schram CJ, Taylor LS, Beaudoin SP. 2015. Influence of polymers on the crystal growth rate of felodipine: correlating adsorbed polymer surface coverage to solution crystal growth inhibition. Langmuir. 31(41):11279–11287. doi:10.1021/acs.langmuir.5b02486.
  • Shi N-Q, Zhang Y, Li Y, Lai H-W, Xiao X, Feng B, Qi X-R. 2017. Self-micellizing solid dispersions enhance the properties and therapeutic potential of fenofibrate: advantages, profiles and mechanisms. Int J Pharm. 528(1–2):563–577. doi:10.1016/j.ijpharm.2017.06.017.
  • Sun DD, Wen H, Taylor LS. 2016. Non-sink dissolution conditions for predicting product quality and in vivo performance of supersaturating drug delivery systems. J Pharm Sci. 105(9):2477–2488. doi:10.1016/j.xphs.2016.03.024.
  • Suryanarayana C. 2001. Mechanical alloying and milling. Prog Mater Sci. 46(1):1–184. doi:10.1016/S0079-6425(99)00010-9.
  • Szafraniec-Szczęsny J, Antosik-Rogóż A, Kurek M, Gawlak K, Górska A, Peralta S, Knapik-Kowalczuk J, Kramarczyk D, Paluch M, Jachowicz R. 2021. How does the addition of Kollidon®VA64 inhibit the recrystallization and improve ezetimibe dissolution from amorphous solid dispersions? Pharmaceutics. 13(2):147. doi:10.3390/pharmaceutics13020147.
  • Thiry J, Lebrun P, Vinassa C, Adam M, Netchacovitch L, Ziemons E, Hubert P, Krier F, Evrard B. 2016. Continuous production of itraconazolebased solid dispersions by hot melt extrusion: Preformulation, optimization and design space determination. International Journal of Pharmaceutics. 515(1): 114–124. doi: 10.1016/j.ijpharm.2016.10.003.
  • Van Krevelen DW, Te Nijenhuis K. 2009. Properties of polymers: their correlation with chemical structure; their numerical estimation and prediction from additive group contributions. Chapter 7 - Cohesive Properties and Solubility, Pages 189-227, ISBN 978-0-08-054819-7 (Fourth edition) Elsevier.
  • Walsh D, Serrano DR, Worku ZA, Madi AM, O'Connell P, Twamley B, Healy AM. 2018. Engineering of pharmaceutical cocrystals in an excipient matrix: spray drying versus hot melt extrusion. Int J Pharm. 551(1-2):241–256. doi:10.1016/j.ijpharm.2018.09.029.
  • Williams HD, Ford L, Han S, Tangso KJ, Lim S, Shackleford DM, Vodak DT, Benameur H, Pouton CW, Scammells PJ, et al. 2018. Enhancing the oral absorption of kinase inhibitors using lipophilic salts and lipid-based formulations. Mol Pharm. 15(12):5678–5696. doi:10.1021/acs.molpharmaceut.8b00858.
  • Williams HD, Trevaskis NL, Charman SA, Shanker RM, Charman WN, Pouton CW, Porter, CJ, H. 2013. Strategies to address low drug solubility in discovery and development. Pharmacol Rev. 65(1):315–499. doi:10.1124/pr.112.005660.
  • Wlodarski K, Sawicki W, Haber K, Knapik J, Wojnarowska Z, Paluch M, Lepek P, Hawelek L, Tajber L. 2015. Physicochemical properties of tadalafil solid dispersions – Impact of polymer on the apparent solubility and dissolution rate of tadalafil. Eur J Pharm Biopharm. 94:106–115. doi:10.1016/j.ejpb.2015.04.031.
  • World Health Organization. 2015 Feb 3. Cancer. https://www.who.int/en/news-room/fact-sheets/detail/cancer.
  • Xia D, Yu H, Tao J, Zeng J, Zhu Q, Zhu C, Gan Y. 2016. Supersaturated polymeric micelles for oral cyclosporine A delivery: the role of Soluplus–sodium dodecyl sulfate complex. Colloids Surf B Biointerfaces. 141:301–310. doi:10.1016/j.colsurfb.2016.01.047.
  • Xie T, Taylor LS. 2016. Improved release of celecoxib from high drug loading amorphous solid dispersions formulated with polyacrylic acid and cellulose derivatives. Mol Pharm. 13(3):873–884. doi:10.1021/acs.molpharmaceut.5b00798.
  • Zhang Q, Zhao Y, Zhao Y, Ding Z, Fan Z, Zhang H, Liu M, Wang Z, Han J. 2018. Effect of HPMCAS on recrystallization inhibition of nimodipine solid dispersions prepared by hot-melt extrusion and dissolution enhancement of nimodipine tablets. Colloids Surf B Biointerfaces. 172:118–126. doi:10.1016/j.colsurfb.2018.08.030.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.